Instil Bio, Inc. (TIL)
7.15
+0.01
(+0.14%)
USD |
NASDAQ |
Sep 30, 16:00
7.15
0.00 (0.00%)
After-Hours: 19:30
Instil Bio Net Income (Quarterly) : -4.299M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.299M |
| March 31, 2026 | -4.204M |
| December 31, 2025 | -8.191M |
| September 30, 2025 | -13.59M |
| June 30, 2025 | -21.39M |
| March 31, 2025 | -28.20M |
| December 31, 2024 | -11.90M |
| September 30, 2024 | -23.02M |
| June 30, 2024 | -14.92M |
| March 31, 2024 | -24.30M |
| December 31, 2023 | -12.92M |
| September 30, 2023 | -67.43M |
| June 30, 2023 | -18.66M |
| Date | Value |
|---|---|
| March 31, 2023 | -57.07M |
| December 31, 2022 | -53.84M |
| September 30, 2022 | -56.22M |
| June 30, 2022 | -58.99M |
| March 31, 2022 | -54.12M |
| December 31, 2021 | -55.35M |
| September 30, 2021 | -43.00M |
| June 30, 2021 | -35.31M |
| March 31, 2021 | -23.13M |
| December 31, 2020 | -17.18M |
| September 30, 2020 | -7.262M |
| June 30, 2020 | -9.202M |
| March 31, 2020 | -4.089M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.299M |
| EPS Diluted (Quarterly) | -0.6339 |
| Enterprise Value | 65.91M |
| Earnings Yield | -62.55% |
| Normalized Earnings Yield | -63.19 |